Risk factors for elastic transformation in myelofibrosis with myeloid metaplasia (MMM).

被引：0
|
作者：
Barosi, G
Quaglini, S
Petti, C
Grossi, A
Pogliani, E
Leoni, P
Rotoli, B
Finelli, C
Foa, P
Ambrosetti, A
Rodeghiero, F
Centra, A
Guarnone, R
Liberato, NL
机构：
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3147 / 3147
页数：1
相关论文
共 50 条
  • [1] Thalidomide treatment in myelofibrosis with myeloid metaplasia (MMM).
    Elliott, MA
    Mesa, RA
    Li, CY
    Hook, CC
    Ansell, SM
    Levitt, R
    Geyer, GM
    Tefferi, A
    BLOOD, 2001, 98 (11) : 627A - 627A
  • [2] Gleevec therapy in myelofibrosis with myeloid metaplasia (MMM).
    Tefferi, AW
    Mesa, RA
    Gray, LA
    Steensma, DP
    Camoriano, JK
    Elliott, MA
    Pardanani, A
    Ansell, SM
    Call, TG
    Colon-Otero, G
    Geyer, SM
    Hanson, CA
    Dewald, GW
    Kaufmann, SH
    BLOOD, 2001, 98 (11) : 626A - 626A
  • [3] Myelofibrosis with myeloid metaplasia (MMM) in young individuals: Disease characteristics, prognostic factors and identification of risk groups
    Cervantes, F
    Barosi, G
    Demory, JL
    Reilly, J
    Guarnone, R
    Dupriez, B
    Pereira, A
    Montserrat, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 283 - 283
  • [4] Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia
    Barosi, G
    Ambrosetti, A
    Centra, A
    Falcone, A
    Finelli, C
    Foa, P
    Grossi, A
    Guarnone, R
    Rupoli, S
    Luciano, L
    Petti, MC
    Pogliani, E
    Russo, D
    Ruggeri, M
    Quaglini, S
    BLOOD, 1998, 91 (10) : 3630 - 3636
  • [5] A pilot study of anagrelide for the treatment of myelofibrosis with myeloid metaplasia (MMM).
    Silverstein, MN
    Tefferi, A
    Li, CY
    Petitt, RM
    BLOOD, 1995, 86 (10) : 3195 - 3195
  • [6] HEMATOPOIETIC CELLULAR PROLIFERATIVE DEFECTS IN MYELOFIBROSIS WITH MYELOID METAPLASIA (MMM)
    CHIKKAPPA, G
    CARSTEN, AL
    CHANANA, AD
    CHANDRA, P
    CRONKITE, EP
    BLOOD, 1977, 50 (05) : 187 - 187
  • [7] Micromegakaryocytic transformation of myelofibrosis with myeloid metaplasia
    Invernizzi, R
    Pecci, A
    Formisano, R
    HAEMATOLOGICA, 2000, 85 (01) : 98 - 99
  • [8] Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia (MMM).
    Elliott, MA
    Chen, MG
    Silverstein, MN
    Tefferi, A
    BLOOD, 1997, 90 (10) : 1545 - 1545
  • [9] Phenotypic differences amongst subgroups of patients with myelofibrosis with myeloid metaplasia (MMM): Analysis of 458 MMM patients.
    Mesa, Ruben
    Niblack, Joyce
    Verstovsek, Srdan
    Barnes, Sunni
    Tan, Angelina
    Atherton, Pamela
    Sloan, Jeffrey
    Tefferi, Ayalew
    BLOOD, 2006, 108 (11) : 306B - 306B
  • [10] Unrelated allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis with myeloid metaplasia (MMM)
    Koldehoff, M
    Basara, N
    Lentini, G
    Pohl, H
    Kiehl, MG
    Fauser, AA
    BONE MARROW TRANSPLANTATION, 2002, 29 : S166 - S166
12345